Thanks for clarifying comments here, much appreciated.
I have to think my initial comment was overly harsh as well, given Supplement 3.
I think all I can say is that it may be possible for this issue to affect their data once they have OS stats accumulated in five years, but it was unlikely to do anything to yield differences in adherence with these kinds of patients over this kind of follow-up length.
I have to think my initial comment was overly harsh as well, given Supplement 3.
I think all I can say is that it may be possible for this issue to affect their data once they have OS stats accumulated in five years, but it was unlikely to do anything to yield differences in adherence with these kinds of patients over this kind of follow-up length.